Literature DB >> 16567531

Coordinate changes in plasma glucose and pancreatic beta-cell function in Latino women at high risk for type 2 diabetes.

Anny H Xiang1, Chengwei Wang, Ruth K Peters, Enrique Trigo, Siri L Kjos, Thomas A Buchanan.   

Abstract

The purpose of this study was to examine longitudinally the relationship among glucose levels, pancreatic beta-cell function, and insulin resistance in women at high risk for type 2 diabetes. Oral glucose tolerance tests (OGTTs) and intravenous glucose tolerance tests (IVGTTs) were performed at 15-month intervals for up to 5 years or until fasting plasma glucose exceeded 140 mg/dl in Hispanic women with recent gestational diabetes. Data were analyzed 1) to compare changes in insulin sensitivity, beta-cell function, and glucose levels between women who had diabetes at one or more visits and women who remained diabetes free and 2) to determine longitudinal patterns of change in glucose levels and acute beta-cell compensation for insulin resistance. Seventy-one women provided data from a total of 280 paired OGTTs and IVGTTs during a median follow-up of 46 months. Compared with the 47 women who remained free of diabetes, the 24 who either had diabetes (n = 9) or developed it during follow-up (n = 15) had higher baseline glucose levels and lower acute beta-cell compensation for insulin resistance. Baseline insulin sensitivity was low in both groups and did not change significantly during follow-up. Fasting and 2-h glucose levels increased more rapidly in the diabetic group despite a decline in acute beta-cell compensation that was significantly slower than the decline in women who did not develop diabetes. This paradox was explained by an accelerated rise in glucose levels for any decline in beta-cell compensation when beta-cell compensation reached approximately 10% of normal, a level that was reached in the women who had or developed diabetes but not in the women who remained diabetes free. These findings define a pathogenesis for type 2 diabetes in one high-risk group that is characterized by a relatively long-term decline in acute beta-cell compensation for chronic insulin resistance that is attended by slowly rising glucose levels. Only relatively late in this process do glucose levels rise rapidly and into the diabetic range.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16567531     DOI: 10.2337/diabetes.55.04.06.db05-1109

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  44 in total

1.  Approach to the patient with gestational diabetes after delivery.

Authors:  Thomas A Buchanan; Kathleen A Page
Journal:  J Clin Endocrinol Metab       Date:  2011-12       Impact factor: 5.958

2.  Common variants at the GCK, GCKR, G6PC2-ABCB11 and MTNR1B loci are associated with fasting glucose in two Asian populations.

Authors:  F Takeuchi; T Katsuya; S Chakrewarthy; K Yamamoto; A Fujioka; M Serizawa; T Fujisawa; E Nakashima; K Ohnaka; H Ikegami; T Sugiyama; T Nabika; A Kasturiratne; S Yamaguchi; S Kono; R Takayanagi; Y Yamori; S Kobayashi; T Ogihara; A de Silva; R Wickremasinghe; N Kato
Journal:  Diabetologia       Date:  2009-11-25       Impact factor: 10.122

3.  High-fat diet is associated with obesity-mediated insulin resistance and β-cell dysfunction in Mexican Americans.

Authors:  Mary Helen Black; Richard M Watanabe; Enrique Trigo; Miwa Takayanagi; Jean M Lawrence; Thomas A Buchanan; Anny H Xiang
Journal:  J Nutr       Date:  2013-01-23       Impact factor: 4.798

4.  θ-Defensin RTD-1 improves insulin action and normalizes plasma glucose and FFA levels in diet-induced obese rats.

Authors:  Young Taek Oh; Dat Tran; Thomas A Buchanan; Michael E Selsted; Jang H Youn
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-05-19       Impact factor: 4.310

5.  Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study.

Authors:  R A DeFronzo; M A Banerji; G A Bray; T A Buchanan; S Clement; R R Henry; A E Kitabchi; S Mudaliar; N Musi; R Ratner; P Reaven; D C Schwenke; F D Stentz; D Tripathy
Journal:  Diabetologia       Date:  2009-12-10       Impact factor: 10.122

6.  Impact of Gastric Banding Versus Metformin on β-Cell Function in Adults With Impaired Glucose Tolerance or Mild Type 2 Diabetes.

Authors:  Anny H Xiang; Enrique Trigo; Mayra Martinez; Namir Katkhouda; Elizabeth Beale; Xinhui Wang; Jun Wu; Ting Chow; Cortney Montgomery; Krishna S Nayak; Fadi Hendee; Thomas A Buchanan
Journal:  Diabetes Care       Date:  2018-10-03       Impact factor: 19.112

7.  Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study.

Authors:  Adam G Tabák; Markus Jokela; Tasnime N Akbaraly; Eric J Brunner; Mika Kivimäki; Daniel R Witte
Journal:  Lancet       Date:  2009-06-08       Impact factor: 79.321

8.  Beta-cell function declines within the first year postpartum in women with recent glucose intolerance in pregnancy.

Authors:  Ravi Retnakaran; Ying Qi; Mathew Sermer; Philip W Connelly; Anthony J G Hanley; Bernard Zinman
Journal:  Diabetes Care       Date:  2010-05-18       Impact factor: 17.152

9.  Pharmacogenetics of Anti-Diabetes Drugs.

Authors:  Johanna K Distefano; Richard M Watanabe
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-01

10.  Declining beta-cell compensation for insulin resistance in Hispanic women with recent gestational diabetes mellitus: association with changes in weight, adiponectin, and C-reactive protein.

Authors:  Anny H Xiang; Miwa Kawakubo; Enrique Trigo; Siri L Kjos; Thomas A Buchanan
Journal:  Diabetes Care       Date:  2009-11-23       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.